Chembio Diagnostics, Inc.

CEMI · NASDAQ
Analyze with AI
12/31/2022
9/30/2022
6/30/2022
3/31/2022
Operating Activities
Net Income-$855-$6,699-$6,946-$8,790
Dep. & Amort.$686$656$613$599
Deferred Tax$0$0$0$0
Stock-Based Comp.$453$536$559$751
Change in WC-$3,122$115$5,006$38
Other Non-Cash$7$331$335$3,034
Operating Cash Flow-$2,832-$5,060-$433-$4,369
Investing Activities
PP&E Inv.$29-$345-$849-$287
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$29-$345-$849-$287
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$388$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$164$3,605-$19-$55
Financing Cash Flow-$164$3,605-$19-$55
Forex Effect$90$18-$261$337
Net Chg. in Cash-$2,876-$1,782-$1,562-$4,374
Supplemental Information
Beg. Cash$21,055$22,837$24,399$28,773
End Cash$18,179$21,055$22,837$24,399
Free Cash Flow-$2,803-$5,405-$1,282-$4,656
Chembio Diagnostics, Inc. (CEMI) Financial Statements & Key Stats | AlphaPilot